GUTSMICRO

Fractyl Health, Inc. Common Stock

HealthcareBiotechnology
$0.74
$0.00(+5.95%)
52W$0.38
$3.03
Updated May 7, 12:00 AM
RSI65
RS Rating31/99
Beta2.15
Volatility134%
F-Score3/9
Mkt Cap$113M
WEAKENING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

WEAKENING

Fractyl Health, Inc. Common Stock is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 31), showing significant lag compared to the market leaders. Earnings growth of 100% provides fundamental context to the price action. However, price is extended 42% above the 50-day line, increasing the risk of a mean reversion.

Relative Strength
31
out of 99
Lagging
Trend Score
1/4
Minervini Criteria
WEAKENING
Risk (Beta)
2.15
vs S&P 500
HIGH BETA
52W Position
14%
from 52W low
Near Low
Trend & Momentum Analysis

Trend Template (Minervini)

WEAKENING1/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$0.52
50 SMA > 100 SMA$1.02
100 SMA > 150 SMA$1.16
150 SMA > 200 SMA$1.17

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$0.59+23.79%ABOVE
50 SMA$0.52+42.15%ABOVE
100 SMA$1.02-27.74%BELOW
150 SMA$1.16-36.39%BELOW
200 SMA$1.17-37.12%BELOW

Price Performance

1D+6.0%
1W+22.1%
1M+63.4%
3M+77.2%
6M-32.6%
YTD-67.3%
1Y-51.0%
3Y-61.5%
52-Week Trading Range14% from low
$0.74
52W Low$0.38
52W High$3.03

Technical Indicators

RSI (14)BULLISH
65.3
305070
VCP ScoreCOOL
2/10
Base depth: 48.3%

Risk Profile

Beta
2.15
52W Vol
134%
ATR
$0.05
Max DD (1Y)
-86%

Volume Analysis

Today
1.10M
50D Avg
1.89M
Vol Ratio
0.58x
Liquidity
ILLIQUID

Earnings Momentum

Q1'25-345%
$-0.49
Q2'25-58%
$-0.57
Q3'25-48%
$-0.71
Q4'25+100%
$0.00
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:
3 Years:
TTM:-100.00%

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:-21.23%

Stock Price CAGR

10 Years:-24.88%
5 Years:-43.57%
3 Years:-61.47%
1 Year:-50.99%

Return on Equity

10Y Avg:-396.6%
5Y Avg:-492.9%
3Y Avg:-492.9%
Last Year:-744.2%

Key Metrics

Market Cap$113M
Gross Margin
Net Margin
Piotroski F-Score3/9

Frequently Asked Questions

Is GUTS in an uptrend right now?

GUTS has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.

Is GUTS overbought or oversold?

GUTS's RSI (14) is 65. The stock is in neutral territory, neither overbought nor oversold.

Is GUTS outperforming the market?

GUTS has a Relative Strength (RS) Rating of 31 out of 99. GUTS is currently lagging the broader market.

Where is GUTS in its 52-week range?

GUTS is trading at $0.74, which is 24% of its 52-week high ($3.03) and 14% above its 52-week low ($0.38).

How volatile is GUTS?

GUTS has a Beta of 2.15 and 52-week volatility of 134%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.